Edoardo Galli

770 total citations
13 papers, 406 citations indexed

About

Edoardo Galli is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Edoardo Galli has authored 13 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Edoardo Galli's work include Multiple Sclerosis Research Studies (8 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Viral Infections and Immunology Research (2 papers). Edoardo Galli is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Viral Infections and Immunology Research (2 papers). Edoardo Galli collaborates with scholars based in Switzerland, Italy and Germany. Edoardo Galli's co-authors include Tobias Derfuß, Burkhard Becher, Ilaria Callegari, Felix J. Hartmann, Florian Ingelfinger, Dunja Mrdjen, Carsten Krieg, Nicholas Sanderson, Martin Diebold and Francesco Lolli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Edoardo Galli

13 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edoardo Galli Switzerland 11 161 145 96 65 57 13 406
Cyra E Leurs Netherlands 13 77 0.5× 260 1.8× 106 1.1× 33 0.5× 68 1.2× 20 427
Johan Mellergård Sweden 10 145 0.9× 215 1.5× 88 0.9× 49 0.8× 63 1.1× 22 394
Ariele L. Greenfield United States 7 168 1.0× 182 1.3× 60 0.6× 82 1.3× 107 1.9× 9 399
Miriam Mattoscio United Kingdom 8 91 0.6× 270 1.9× 58 0.6× 61 0.9× 84 1.5× 11 391
Kazuyuki Kawamura Japan 13 231 1.4× 102 0.7× 145 1.5× 104 1.6× 82 1.4× 22 479
Irati Zubizarreta Spain 15 72 0.4× 384 2.6× 122 1.3× 51 0.8× 111 1.9× 23 564
Damiano Marastoni Italy 12 95 0.6× 278 1.9× 67 0.7× 122 1.9× 124 2.2× 35 433
John Soltys United States 9 114 0.7× 203 1.4× 69 0.7× 63 1.0× 183 3.2× 18 393
C. Butter United Kingdom 11 288 1.8× 166 1.1× 108 1.1× 146 2.2× 47 0.8× 15 583
Rehiana Ali United Kingdom 7 64 0.4× 169 1.2× 33 0.3× 39 0.6× 87 1.5× 8 262

Countries citing papers authored by Edoardo Galli

Since Specialization
Citations

This map shows the geographic impact of Edoardo Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Galli more than expected).

Fields of papers citing papers by Edoardo Galli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Galli. The network helps show where Edoardo Galli may publish in the future.

Co-authorship network of co-authors of Edoardo Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Edoardo Galli. A scholar is included among the top collaborators of Edoardo Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edoardo Galli. Edoardo Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Müller, Jannis, Izanne Roos, Tomáš Kalinčík, et al.. (2024). Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis. Brain and Behavior. 14(5). e3498–e3498. 2 indexed citations
2.
Galli, Edoardo, Bettina Schreiner, Mohsen Khademi, et al.. (2023). B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis. Cell Reports Medicine. 5(1). 101351–101351. 10 indexed citations
3.
Callegari, Ilaria, Tobias Mühlethaler, Edoardo Galli, et al.. (2022). Potent neutralization by monoclonal human IgM against SARS‐CoV‐2 is impaired by class switch. EMBO Reports. 23(7). e53956–e53956. 12 indexed citations
4.
Diebold, Martin, Edoardo Galli, Andreas Köpf, et al.. (2022). Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia. Annals of Neurology. 91(5). 676–681. 9 indexed citations
5.
Diebold, Martin, Edoardo Galli, Andreas Köpf, et al.. (2022). High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis. Proceedings of the National Academy of Sciences. 119(31). e2205042119–e2205042119. 19 indexed citations
6.
Callegari, Ilaria, Tobias Derfuß, & Edoardo Galli. (2021). Update on treatment in multiple sclerosis. La Presse Médicale. 50(2). 104068–104068. 38 indexed citations
7.
Johansson, David, Julien Roux, Edoardo Galli, et al.. (2021). Mass Cytometry of CSF Identifies an MS-Associated B-cell Population. Neurology Neuroimmunology & Neuroinflammation. 8(2). 23 indexed citations
8.
Galli, Edoardo, Felix J. Hartmann, Bettina Schreiner, et al.. (2019). GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis. Nature Medicine. 25(8). 1290–1300. 135 indexed citations
9.
Galli, Edoardo, Ekaterina Friebel, Florian Ingelfinger, et al.. (2019). The end of omics? High dimensional single cell analysis in precision medicine. European Journal of Immunology. 49(2). 212–220. 24 indexed citations
10.
Hartmann, Felix J., Raphaël Bernard‐Valnet, Clémence Queriault, et al.. (2016). High-dimensional single-cell analysis reveals the immune signature of narcolepsy. The Journal of Experimental Medicine. 213(12). 2621–2633. 76 indexed citations
11.
Matà, Sabrina, Edoardo Galli, A. Amantini, et al.. (2006). Anti‐ganglioside antibodies and elevated CSF IgG levels in Guillain‐Barré syndrome. European Journal of Neurology. 13(2). 153–160. 25 indexed citations
12.
Lolli, Francesco, G. Siracusa, Maria Pia Amato, et al.. (1991). Intrathecal synthesis of free immunoglobulin light chains and IgM in initial multiple sclerosis. Acta Neurologica Scandinavica. 83(4). 239–243. 22 indexed citations
13.
Lolli, Francesco, Maria Grazia Colao, Elisa Maio, et al.. (1990). Intrathecal synthesis of anti-HIV antibodies in AIDS patients. Journal of the Neurological Sciences. 99(2-3). 281–289. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026